Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribociclib in Advanced Well-Differentiated or Dedifferentiated Liposarcoma
NCT03096912Phase 2Unknown
- Sponsor
- Shamir Medical Center
- Start
- Jul 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ribociclib in Liposarcoma, dedifferentiated liposarcoma (DDL), sponsored by Shamir Medical Center. Status: unknown.
02
Drugs
ribociclib
03
Conditions
Liposarcomadedifferentiated liposarcoma (DDL)
Beyond the preview
Go deeper on NCT03096912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03096912.